ECCPM FORUM 2026
Sep 14-16, 2026 | Graz, Austria
SUPPLY CHAIN SECURITY & FAST CRISIS RESPONSE IN THE ERA OF CONTINUOUS MANUFACTURING
Supply Chains. Regulation. Innovation.
The ECCPM Forum 2026 is a two-day event bringing together over 100 senior professionals from pharmaceuticals, regulatory bodies, and leading research institutions.
Focused on regulatory innovation, supply chain security, and rapid crisis response in continuous manufacturing, it offers a dynamic platform for strategic dialogue at the intersection of technology, regulation, and sustainability.
ECCPM Forum 2026 will offer insights on
- Supply chain security in the era of continuous manufacturing
- Regulatory agility in times of crisis
- Innovations in drug products and substance manufacturing
- Green and digital twin transformation
- Prediction, simulation, and machine learning in pharmaceutical production
100
Participants
6
Keynote Lectures
16
Expert Talks
Training Day & Networking
The forum opens with a training day, where RCPE experts offer three in-depth workshops on resilience technologies, adaptive manufacturing strategies, and risk management along the supply chain. These formats equip participants with practical insights ahead of the main conference.
Over the following two days, a distinguished international panel will explore how industry and regulators can jointly strengthen pharmaceutical supply networks.
Explore ECCPM
The challenges addressed by the ECCPM Forum are clear: mounting supply chain vulnerabilities, climate commitments, and increasingly dynamic regulatory frameworks.
By looking at continuous manufacturing as a resilience enabler, digital twins and real-time analytics for risk prevention, and sustainable technologies that align supply security with environmental goals, the forum positions itself as a forward-looking hub for joint solutions.
Sessions
Opening Session: Securing Pharmaceutical Supply Chains in the Era of Continuous Manufacturing
This session will explore strategies to anticipate, prevent, and respond effectively to global health and security crises. The focus of the keynote lecture and the subsequent panel discussion will be on the strategic development, procurement, and robust stockpiling of medical countermeasures (MCM) such as vaccines, therapeutics, diagnostics, and protective equipment. Key topics include intelligence-driven risk mitigation, continuous manufacturing technologies, adaptable production capacity, as well as coordinated international collaboration can ensure rapid, resilient, and equitable access to critical medical supplies. The session will also examine the role of dual-use technologies and interoperable defense innovations in enhancing supply chain resilience. The goal is to bring together experts and stakeholders from health, industry, research, and security sectors to jointly establish sustainable frameworks for future crises.
Session 1: Regulatory Authorities as Enhancers of Innovation
Regulatory authorities are critical partners in advancing innovation and, even more so, in enabling effective crisis response. This session examines how supportive frameworks, collaboration, and standards like ICH Q13 help accelerate new technologies and bolster supply chain resilience. Which new ideas and bold approaches could move the needle even further?
Chair: Johannes Khinast
Session 2: Advances in Drug Product Manufacturing
Advanced and enabling pharmaceutical technologies – ranging from digital tools and sustainable approaches to continuous & on-demand manufacturing – are transforming drug product manufacturing. The focus is on resilient, high-quality, and patient-centric solutions that strengthen supply chains and ensure safe, efficient, and flexible production.
Chairs: Stephan Sacher & Martin Spörk
Session 3: Advances in Drug Substance Manufacturing
Process intensification combined with green and enabling synthetic technologies – including continuous manufacturing and flow chemistry – enables the production of APIs and critical intermediates in a safe and sustainable fashion. This approach supports the reshoring of critical medicines manufacturing to Europe.
Chair: C. Oliver Kappe
Session 4: Green & Digital Twin Transformation
Digital innovation and green strategies are transforming pharmaceutical manufacturing. Focus is on the integration of advanced analytics, AI, and GenAI with sustainable practices to drive efficiency, regulatory compliance, and environmental responsibility. Case studies illustrate how digitalization enables scalable, transparent, and resilient solutions for eco-friendly pharma production.
Chair: Gert Breitfuss
Session 5: Prediction, Simulation, and Machine Learning
The integration of modeling and simulation are reshaping every stage of pharmaceutical product development – from research and development to production and supply chain optimization. The discussion will focus on how novel models are created and validated, what sets mechanistic and AI-driven approaches apart, and practical requirements for integrating these modeling tools into daily workflows. How can mechanistic and AI models be combined? And what does it take to approach regulatory drug filing supported by digital tools and predictions?
Chairs: Benedict Benque & Josip Matić
Get your Ticket
Join leading experts and researchers at the ECCPM Forum 2026. Take advantage of early-bird registration and secure your place today.
The ECCPM Forum 2026 fosters a collaborative dialogue between regulators, academia, and industry, helping all stakeholders to shape secure, responsive, and sustainable pharmaceutical manufacturing and distribution for the future.